Joel Greenblatt · Magic Formula: alta rentabilidad del capital a un EV/EBIT bajo
Is Apellis Pharmaceuticals, Inc. (APLS) a Joel Greenblatt Stock?
Partial match: either cheap or high-quality, but not both.
59/100
Mixto
1/5 criterios cumplidos
Los criterios de Joel Greenblatt, aplicados a APLS
EBIT/EV yield ≥ 10%
clave1.0%
ROIC ≥ 25%
clave18.1%
EV/EBIT ≤ 12
96.0x
Gross margin ≥ 30%
90.1%
Cómo se valora APLS en otras estrategias
Datos financieros en vivo
Cap. mercado
$5.25B
PER (TTM)
38.8x
ROIC (TTM)
18.11%
Margen bruto
90.12%
Otros análisis Joel Greenblatt
Preguntas frecuentes
What is APLS's Joel Greenblatt fit score?
APLS scores 59/100 on our Joel Greenblatt fit engine. Partial match: either cheap or high-quality, but not both.
Does Joel Greenblatt actually own APLS?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends APLS.
How often is this score updated?
APLS's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Joel Greenblatt posea o recomiende APLS personalmente.
